4.5 Article

Principal stratification in causal inference

Journal

BIOMETRICS
Volume 58, Issue 1, Pages 21-29

Publisher

INTERNATIONAL BIOMETRIC SOC
DOI: 10.1111/j.0006-341X.2002.00021.x

Keywords

biomarker; causal inference; censoring by death; missing data; posttreatment variable; principal stratification; quality of life; Rubin causal model; surrogate

Funding

  1. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038209] Funding Source: NIH RePORTER
  2. NATIONAL EYE INSTITUTE [R01EY014314] Funding Source: NIH RePORTER
  3. NATIONAL INSTITUTE ON DRUG ABUSE [R01DA038209] Funding Source: NIH RePORTER
  4. NEI NIH HHS [R01 EY014314] Funding Source: Medline
  5. NICHD NIH HHS [R01 HD38209] Funding Source: Medline
  6. NIDA NIH HHS [R01 DA038209] Funding Source: Medline

Ask authors/readers for more resources

Many scientific problems require that treatment comparisons be adjusted for posttreatment variables, butZ the estimands underlying standard methods are not causal effects. To address this deficiency, we propose a general framework for comparing treatments adjusting for posttreatment variables that yields principal effects based on principal stratification. Principal stratification with respect to a post treatment variable is a cross-classification of subjects defined by the joint potential values of that posttreatment variable under each of the treatments being compared. Principal effects are causal effects within a principal stratum. The key property of principal strata is that they are not affected by treatment assignment and therefore can be used just as any pretreatment covariate, such as age category. As a result, the central property of our principal effects is that they are always causal effects and do not suffer front the complications of standard posttreatment-adjusted estimands. We discuss briefly that such principal causal effects are the link between three recent applications with adjustment for posttreatment variables: (i) treatment noncompliance, (ii) missing outcomes (dropout) following treatment noncompliance, and (iii) censoring by death. We then attack the problem of surrogate or biomarker endpoints, where we show, using principal causal effects, that all current definitions of surrogacy, even when perfectly true, do not generally have the desired interpretation as causal effects of treatment on outcome. We go on to formulate estimands based on principal stratification and principal causal effects and show their superiority.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available